In addition, it reduced tau hyperphosphorylation by inhibiting cdk5, whereas in a triple transgenic AD mouse model, it attenuated hyperphosphorylation of tau by inhibiting the activity of GSK-3β [292,293]. This evidence concerns the gene MAPT and Alzheimer disease.